Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

May 11, 2012

Mylan Launches Generic Lipitor® in Five European Countries

May 10, 2012

Mylan Increases 2012 Guidance Range to $2.45 to $2.55 in Adjusted Diluted EPS

Apr 30, 2012

Mylan Launches First Generic Version of Doryx® 150 mg

Apr 30, 2012

Mylan Announces Settlement Agreement for its First-to-File Generic Version of Nuvigil®

Apr 28, 2012

Mylan to Partner with United Nations and Clinton Health Access Initiative to Fight Diarrhea Fatalities in Children in India

Apr 26, 2012

Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter

Apr 26, 2012

Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva

Apr 24, 2012

Mylan Launches Generic Version of Zyprexa® Tablets

Apr 18, 2012

Mylan Announces Expansion in Ireland

Apr 13, 2012

Mylan Launches First Generic Version of Lescol® Capsules

Pagination

First page
Previous page
…
Page 61
Page 62
Page 63
Page 64
Current page 65
Page 66
Page 67
Page 68
Page 69
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.